Tag: Ageing & Pharmacology
-
Recognition of our impact on the world stage
Posted on:
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study
Category:
-
Philanthropic funds creating travel opportunities
Posted on:
A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust. Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills. It’s anticipated the travel program
Category:
-
Recognition for our up and coming stars
Posted on:
Several high profile awards are highlighting the emerging talent within the Kolling’s Laboratory of Ageing and Pharmacology. Led by Professor Sarah Hilmer, the team is driving research to improve the quality use of medicines particularly by older adults. Two prestigious awards were presented to researchers at a national event in Perth showcasing new investigators in
Category:
-
Kolling researcher recognised on the international stage
Posted on:
Congratulations to research fellow Dr Lisa Kouladjian O’Donnell who has received a prestigious award for her contribution to pharmacology. Lisa was presented with the ASCEPT Early Achievement Award for Women during the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. This year’s event was held in Perth in collaboration with
Category:
-
Study finds multiple medications impact how we age and the health of our gut
Posted on:
A new study by researchers at the Kolling Institute, in collaboration with the Microbiome Research Centre, has shown that multiple medication use impacts gut microbiome, and may influence the ageing process. Gizem Gemikonakli, a PhD student at the University of Sydney, said their findings followed a longitudinal, in vivo study. “Interestingly, mice that were given
Category:
-
Outstanding career recognised with national accolade
Posted on:
We would like to congratulate Kolling Institute researcher Professor Sarah Hilmer who has been elected a Fellow of the prestigious Australian Academy of Health and Medical Sciences. Professor Hilmer is part of a select group of researchers who have been admitted to the academy, which works to advance health and medical research across Australia. She
Category:
-
Innovative research on show
Posted on:
An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The
-
Remarkable service recognised in Queen’s birthday honours
Posted on:
We would like to congratulate our Kolling Institute researcher Professor Sarah Hilmer who’s been awarded an AM for her service to clinical and geriatric pharmacology as part of the Queen’s birthday honours. Professor Hilmer has worked as the Head of Clinical Pharmacology and as a geriatrician at Royal North Shore Hospital since 2005. Her research
Category:
-
The Kolling’s up and coming talent recognised
Posted on:
Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute. Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Committee.
Category:
-
Researchers develop new program to reduce medication burden
Posted on:
A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines. Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain. Cumulatively however, they can cause serious adverse effects such
Category: